Clinically, BC is divided into four subtypes determined by the expression levels of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).Standard treatments entail chemotherapy, hormone therapy, and targeted therapy, tailored to the subtype. This evidence concerns the gene ERBB2 and breast cancer.